Haleon announced that Eroxon, the first-and-only FDA cleared gel available without a prescription for the treatment of erectile dysfunction, is now available for pre-order in the U.S. through Amazon and will be available at most major retailers in October. Eroxon is clinically proven to help men get an erection within 10 minutes. Clinical study results show that Eroxon is safe and effective in men with ED.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLN:
- Haleon PLC Sponsored ADR (HLN) Unveils Dividend Details for Q3: Mark Your Calendar!
- Haleon U.S. shares initiated with a Buy at Berenberg
- Haleon downgraded to Neutral from Buy at Goldman Sachs
- Haleon price target raised to 385 GBp from 370 GBp at Morgan Stanley
- Haleon price target raised to 410 GBp from 385 GBp at Jefferies
Questions or Comments about the article? Write to editor@tipranks.com